title: Application of pharmacogenetics: UGT1A1*28 and nilotinib-induced unconjugated hyperbilirubinaemia in a patient with chronic myeloid leukaemia.
authors: Sammy Pak-lam
authors: SP
authors: Chen
authors: Wing-tat
authors: WT
authors: Poon
authors: Chloe Miu
authors: CM
authors: Mak
authors: Ching-wan
authors: CW
authors: Lam
authors: Yok-lam
authors: YL
authors: Kwong
authors: Albert Yan-wo
authors: AY
authors: Chan
authors: Sidney
authors: S
authors: Tam
mesh_terms: D000368:Aged; D001663:Bilirubin / Q000097:blood; D020022:Genetic Predisposition to Disease; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D008297:Male; D025202:Molecular Diagnostic Techniques; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000009:adverse effects* / Q000493:pharmacokinetics; D000099148:UGT1A1 Enzyme
chemical_list: D001663:Bilirubin; D014453:Glucuronosyltransferase; D011505:Protein-Tyrosine Kinases; D011743:Pyrimidines; D000099148:UGT1A1 Enzyme; C498826:nilotinib